The ultimate objective of the research projects in this application is to improve our understanding of, and our therapeutic options in, lymphomas arising from germinal center cells. Members of the Biostatistics Core will provide assistance in the design and analysis of the clinical, murine, and laboratory research projects. The purpose of the Biostatistics Core is to provide the following services: 1. To provide biostatistical collaboration for clinical research protocols, including all aspects of the design, conduct, analysis, and reporting of the clinical studies. 2. To provide biostatistical collaboration for all laboratory studies conducted in Projects 5 and 6 or through Core C, including all aspects of the design, conduct, analysis, and reporting of such studies, with emphasis on the correlation of laboratory results with clinical parameters and outcomes. 3. To provide biostatistical collaboration for gene expression profiling studies, including all aspects of design, and, in collaboration with Core A, analysis with regard to clustering and classification by clinical parameters and by outcome. 4. To provide biostatistical collaboration for murine studies, with or without laboratory correlative components, including all aspects of the design and analysis of such studies. 5. To assist in the supervision of data management for the clinical studies. 6. To oversee the computerization and quality assurance activities of the Quality Control Center, with respect to clinical and laboratory data collected on the clinical studies. 7. To oversee the computerization, quality assurance, and retrieval programs for the pathology database of Core B, and to assist with the design, analysis, and reporting of studies linking pathology results to clinical information.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA092625-02
Application #
6614502
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-07-22
Project End
2003-06-30
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Chapuy, Bjoern; Cheng, Hongwei; Watahiki, Akira et al. (2016) Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease. Blood 127:2203-13
Zhang, Baochun; Calado, Dinis Pedro; Wang, Zhe et al. (2015) An oncogenic role for alternative NF-?B signaling in DLBCL revealed upon deregulated BCL6 expression. Cell Rep 11:715-26
Carey, Christopher D; Gusenleitner, Daniel; Chapuy, Bjoern et al. (2015) Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens. J Mol Diagn 17:19-30
Gostissa, Monica; Bianco, Julia M; Malkin, Daniel J et al. (2013) Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas. Proc Natl Acad Sci U S A 110:2934-9
Yan, Qingsheng; Xu, Rong; Zhu, Liya et al. (2013) BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8. Mol Cell Biol 33:845-57
Ying, Carol Y; Dominguez-Sola, David; Fabi, Melissa et al. (2013) MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma. Nat Immunol 14:1084-92
Chen, Linfeng; Monti, Stefano; Juszczynski, Przemyslaw et al. (2013) SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas. Cancer Cell 23:826-38
Rossi, Davide; Rasi, Silvia; Spina, Valeria et al. (2013) Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood 121:1403-12
Monti, Stefano; Chapuy, Bjoern; Takeyama, Kunihiko et al. (2012) Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma. Cancer Cell 22:359-72
Cohen, Nicole A; Stewart, Michelle L; Gavathiotis, Evripidis et al. (2012) A competitive stapled peptide screen identifies a selective small molecule that overcomes MCL-1-dependent leukemia cell survival. Chem Biol 19:1175-86

Showing the most recent 10 out of 124 publications